NICOLE EGGEBRECHT: Open Payments
NPI 1710216379 · OSPREY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$687 in 23 payments from 11 companies in 2025. Trend: 2023 $774 · 2024 $731 · 2025 $687
Food & beverage: $687
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $158 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Exact Sciences Corporation | 4 | $120 |
| SANOFI-AVENTIS U.S. LLC | 2 | $72 |
| Novo Nordisk Inc | 2 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| PFIZER INC. | 2 | $42 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| Amgen Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: VOQUEZNA, BREZTRI, Cologuard Collection Kit, TZIELD, AIRSUPRA, Ozempic, GEMTESA, ELIQUIS.
Industry payments across FL — which companies pay providers there.
